Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $240.55 | Total: $1,202.75 |
| 1 | 10 | $203.76 | Total: $2,037.60 |
| 1 | 25 | $172.63 | Total: $4,315.75 |
| 1 | 50 | $147.16 | Total: $7,358.00 |
| 1 | 100 | $127.35 | Total: $12,735.01 |
Overview
L162389 is an orally active and potent angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor subtypes that stimulates the conversion of phosphatidylinositol.
Chemical Properties
| Molecular Formula | C31H38N4O4S |
| Molecular Weight | 562.72 |
| CAS Numbers | 169281-53-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O=C(OCCCC)NS(=O)(=O)C=1C=CC(=CC1C2=CC=C(C=C2)CN3C4=NC(=CC(=C4N=C3CC)C)C)CCC |
Storage and Handling
0C Short Term, -20C Long Term
References
Perlman S, et al. Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands susceptibility to receptor mutations. Mol Pharmacol. 1997 Feb;51[2] 301-11.